Redução do MELD em paciente na lista de transplante hepático após o uso de aminoácidos de cadeia ramificada: Relato de caso
Carregando...
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Acesso restrito
Resumo
Liver cirrhosis (LC) is a disease with high mortality rates and its only definitive treatment is the orthotopic liver transplantation (OLT). Unfortunately, not all patients have access to OLT and many of them end up dying on the transplant waiting list. The use of branched chain amino acids (BCAA) is widely known as an effective treatment for improving the quality of life of these patients. For the first time, in this paper we documented a great improvement of clinical and laboratorial tests of a patient treated with BCAA, which allowed him to be out of the transplant waiting list. In addition to the increase of the MELD score, the patient achieved restabilization of body weight and recovery of the quality of life registered by the SF-36 questionnaire.
Descrição
Palavras-chave
Branched chain amino acid, Hepatic cirrhosis, Hepatic encephalopathy, Hepatic transplant
Idioma
Português
Citação
GED - Gastrenterologia Endoscopia Digestiva, v. 33, n. 2, p. 61-65, 2014.
Itens relacionados
Financiadores
Outras formas de acesso
